表紙
市場調查報告書

幹細胞研究的全球市場

Stem Cells

出版商 Global Industry Analysts, Inc. 商品編碼 243086
出版日期 內容資訊 英文 162 Pages
商品交期: 最快1-2個工作天內
價格
幹細胞研究的全球市場 Stem Cells
出版日期: 2020年09月01日內容資訊: 英文 162 Pages
簡介

本報告,分析幹細胞研究的全球市場,提供美國/歐洲/其他地區的全面地區別分析,推估/預測2008-2017年的年度業績,同時彙整主要/利基參與者共87家的企業檔案資料,由下列摘要形式闡述。

第1章 簡介、方法論、產品定義

第2章 報告摘要

第3章 市場概要

  • 概要
  • 過去的主要成果
  • 幹細胞研究上的歷史大事件
  • 新成長領域
  • 整型外科用產品:具潛力的成長部門
  • 臍帶血幹細胞的實用功能
  • 課題
  • 幹細胞研究與倫理角度

第4章 市場的動態與趨勢

  • 北美支配全球的幹細胞市場
  • 幹細胞的躍進重新形成醫療領域
  • 韓國公開世界最初的體性幹細胞式治療
  • 對新技術的莫大關注
  • 倫理問題與發生期狀態:幹細胞的主要市場阻礙因素
  • 幹細胞治療上的醫療旅遊的上昇
  • 政府法規無法防止幹細胞治療的醫療旅遊
  • 幹細胞專利上美國與日本創造出與歐洲的巨大差距

第5章 幹細胞市場動態:種類別

  • 成體幹細胞所握有的莫大可能性
  • 成體幹細胞與胚胎幹細胞:比較
  • 低風險的投資
  • 成體幹細胞聚集較多的研究用投資
  • 低通用性:成體幹細胞的主要限制因素
  • 造血幹細胞:享受持續的成功
  • 阻礙因素
  • 間質幹細胞:具潛力的治療選項
  • 隔離性的難度與低理解度阻礙成長
  • 誘發型多功能幹細胞:ESC的替代
  • iPS發現的概要
  • 醫藥品開發:iPS的主要應用
  • 再生醫療
  • iPS細胞銀行的建立
  • 難治性/先天性疾病的治療
  • 內臟器官治療
  • 胚胎幹細胞改變了醫療領域
  • 安全性與有效性資料的不足持續為問題

第6章 用途別幹細胞研究

  • 疾病管理上的幹細胞
  • 再生醫療上的幹細胞治療
  • 幹細胞治療:對神經障礙具潛力的治療
  • 被要求大規模研究的心臟血管疾病上的早期成果建立
  • 癌症的幹細胞治療
  • 跨足個人醫療的幹細胞
  • 高齡化人口所促進的整型外科幹細胞市場
  • 其他疾病
  • 藥物傳遞上的幹細胞
  • 醫藥品開發用工具

第7章 法規環境

  • 支配幹細胞研究的法律:分裂的世界
  • 主要國家的幹細胞研究相關法律與規範

第8章 產品概要

  • 幹細胞研究
  • 幹細胞:解說
  • 幹細胞的種類
  • 胚胎幹細胞
  • 成體幹細胞
  • 其他主要細胞種類
  • 幹細胞:特性
  • 自然再生能力
  • 可能性
  • 多樣潜在力的定義
  • 幹細胞的辨識
  • 幹細胞:應用
  • 幹細胞的歷史
  • 幹細胞:服務與產品
  • 幹細胞產品/服務的重大性

第9章 研究的飛躍式發現

第10章 產品介紹/創新

第11章 近期業界活動

第12章 策略企業發展:歷史展望材料

第13章 關注全球的主要參與者

第14章 全球市場展望

  • 美國
  • 歐洲
  • 其他地區

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6142

Global Stem Cells Market to Reach $15.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Stem Cells estimated at US$9.1 Billion in the year 2020, is projected to reach a revised size of US$15.1 Billion by 2027, growing at aCAGR of 7.4% over the period 2020-2027. Adult Stem Cells, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$12.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Other Product Types segment is readjusted to a revised 8.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.7 Billion, While China is Forecast to Grow at 6.9% CAGR

The Stem Cells market in the U.S. is estimated at US$2.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2027 trailing a CAGR of 6.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.9% and 6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6% CAGR.We bring years of research experience to this 16th edition of our report. The 162-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • apceth Biopharma GmbH
  • Athersys Inc.
  • AVIVA BioSciences Corporation
  • BioE Inc.
  • Bone Therapeutics SA
  • Cesca Therapeutics Inc.
  • Cryo-Cell International Inc.
  • Cytori Therapeutics Inc.
  • ESI BIO
  • Gamida Cell Ltd.
  • Holostem Terapie Avanzate
  • International Stem Cell Corp.
  • Kangstem Biotech. Ltd.
  • Lonza Group Ltd.
  • Mesoblast Ltd.
  • Neuralstem Inc.
  • Nuvasive Inc.
  • OncoMed Pharmaceuticals Inc.
  • Osiris Therapeutics Inc.
  • Promethera Biosciences S.A.N.V
  • Reliance Life Sciences
  • ReNeuron Group Plc.
  • Stemcell Technologies Inc.
  • Stemedica Cell Technologies Inc.
  • Stempeutics Research Pvt. Ltd.
  • Takara Bio USA Inc.
  • TiGenix NV
  • U.S Stem Cell Inc.
  • ViaCord

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Stem Cells - Offering Potential for Breakthrough Therapeutic Discoveries
    • Recent Market Activity
    • Select Approved Stem Cell Products
    • Stem Cells Bypass Use of Animal Models in Drug Discovery Programs
    • Trends Related to Stem Cell Clinical Trials
    • Select Stem Cell Pipeline Analysis
    • Current & Future Analysis
    • Stem Cell Research Funding Policies across the World
    • Japan and US - Pioneering Induced Pluripotent Stem Cell (iPSC) Research
    • Adult Stem Cells Deemed More Ethical, More Research Needed to Increase Clinical Applications
    • Dental Mesenchymal Stem Cells - Emergence of a Niche Market
    • For-Profit, Unregulated Clinics: The Flipside of Stem Cell Research
    • Unproven Therapies Do Online Rounds as Effective Treatment Options - A Cause of Concern
    • Global Competitor Market Shares
    • Stem Cells Competitor Market Share Scenario Worldwide (in %): 2020 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • Athersys, Inc. (USA)
    • Apceth GmbH & Co.KG (Germany)
    • AVIVA BioSciences Corporation (USA)
    • BioE, Inc. (USA)
    • Bone Therapeutics SA (Belgium)
    • Cesca Therapeutics, Inc. (USA)
    • Cryo-Cell International, Inc. (USA)
    • Cytori Therapeutics, Inc. (USA)
    • ESI BIO, a Division of BioTime Inc. (USA)
    • Gamida Cell Ltd. (Israel)
    • Holostem Terapie Avanzate (Italy)
    • International Stem Cell Corporation (USA)
    • Kangstem Biotech., Ltd. (Korea)
    • Lonza Group Ltd (Switzerland)
    • Mesoblast Ltd. (Australia)
    • Neuralstem, Inc. (USA)
    • Nuvasive, Inc. (USA)
    • Osiris Therapeutics, Inc. (USA)
    • OncoMed Pharmaceuticals, Inc (USA)
    • PROMETHERA Biosciences S.A.N.V (Belgium)
    • Reliance Life Sciences (India)
    • ReNeuron Group Plc. (UK)
    • STEMCELL Technologies, Inc. (Canada)
    • Stemedica Cell Technologies, Inc (USA)
    • Stempeutics Research Pvt. Ltd. (India)
    • Takara Bio USA Inc (USA)
    • TiGenix NV (Belgium)
    • U.S Stem Cell, Inc. (USA)
    • ViaCord, LLC (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Researchers at UCLA Successfully Develop 3D Lung Organoids using Stem Cells
    • Embryonic Stem Cell Gene Nanog Found to Reverse Aging
    • Canadian and Dutch Scientists Finds the "Genetic Switch" to Increase Stem Cell Volume from Cord Blood
    • The Boston Program Pioneers Cell-based Personalized Diabetes Treatment
    • iPSCs Provide Valuable Source for Retinal Transplants and Other Applications
    • Albumin-Free Culture of Pluripotent Stem Cells Enables Application in Cardiac Disorders
    • Stem Cell Therapy - An Alternative to Orthopedic Surgery in Younger Patients?
    • Application of Plant Stem Cells in Cosmetic Treatments - Myths Busted
    • Adverse Reactions of Stem Cell-Face Lift Therapy
    • Stem Cell-Breast Enhancement
    • Other Innovations Using Stem Cells
    • New Stem Cell Software & Products
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: Stem Cells Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 2: Stem Cells Market Share Shift across Key Geographies Worldwide: 2020 VS
    • TABLE 3: Adult Stem Cells (Product Type) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 4: Adult Stem Cells (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS
    • TABLE 5: Other Product Types (Product Type) Potential Growth Markets Worldwide in US$ Million: 2020 to
    • TABLE 6: Other Product Types (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS
    • TABLE 7: Regenerative Medicine (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020
    • TABLE 8: Regenerative Medicine (Application) Market Share Breakdown by Region/Country: 2020 VS
    • TABLE 9: Drug Discovery & Development (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2020
    • TABLE 10: Drug Discovery & Development (Application) Share Breakdown Review by Region/Country: 2020 VS

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Stem Cells Market Share (in %) by Company: 2020 &
    • Market Analytics
    • TABLE 11: United States Stem Cells Market Estimates and Projections in US$ Million by Product Type: 2020 to
    • TABLE 12: United States Stem Cells Market Share Breakdown by Product Type: 2020 VS
    • TABLE 13: United States Stem Cells Latent Demand Forecasts in US$ Million by Application: 2020 to
    • TABLE 14: Stem Cells Market Share Breakdown in the United States by Application: 2020 VS
  • CANADA
    • TABLE 15: Canadian Stem Cells Market Estimates and Forecasts in US$ Million by Product Type: 2020 to
    • TABLE 16: Stem Cells Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2020 and
    • TABLE 17: Canadian Stem Cells Market Quantitative Demand Analysis in US$ Million by Application: 2020 to
    • TABLE 18: Canadian Stem Cells Market Share Analysis by Application: 2020 VS
  • JAPAN
    • TABLE 19: Japanese Market for Stem Cells: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020
    • TABLE 20: Japanese Stem Cells Market Share Analysis by Product Type: 2020 VS
    • TABLE 21: Japanese Demand Estimates and Forecasts for Stem Cells in US$ Million by Application: 2020 to
    • TABLE 22: Stem Cells Market Share Shift in Japan by Application: 2020 VS
  • CHINA
    • TABLE 23: Chinese Stem Cells Market Growth Prospects in US$ Million by Product Type for the Period 2020
    • TABLE 24: Chinese Stem Cells Market by Product Type: Percentage Breakdown of Sales for 2020 and
    • TABLE 25: Chinese Demand for Stem Cells in US$ Million by Application: 2020 to
    • TABLE 26: Chinese Stem Cells Market Share Breakdown by Application: 2020 VS
  • EUROPE
    • Market Facts & Figures
    • European Stem Cells Market: Competitor Market Share Scenario (in %) for 2020 &
    • Market Analytics
    • TABLE 27: European Stem Cells Market Demand Scenario in US$ Million by Region/Country: 2018
    • TABLE 28: European Stem Cells Market Share Shift by Region/Country: 2020 VS
    • TABLE 29: European Stem Cells Market Estimates and Forecasts in US$ Million by Product Type: 2020
    • TABLE 30: European Stem Cells Market Share Breakdown by Product Type: 2020 VS
    • TABLE 31: European Stem Cells Addressable Market Opportunity in US$ Million by Application: 2020
    • TABLE 32: European Stem Cells Market Share Analysis by Application: 2020 VS
  • FRANCE
    • TABLE 33: Stem Cells Market in France by Product Type: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 34: French Stem Cells Market Share Analysis by Product Type: 2020 VS
    • TABLE 35: Stem Cells Quantitative Demand Analysis in France in US$ Million by Application: 2020
    • TABLE 36: French Stem Cells Market Share Analysis: A 7-Year Perspective by Application for 2020 and
  • GERMANY
    • TABLE 37: Stem Cells Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020
    • TABLE 38: German Stem Cells Market Share Breakdown by Product Type: 2020 VS
    • TABLE 39: Stem Cells Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020
    • TABLE 40: Stem Cells Market Share Distribution in Germany by Application: 2020 VS
  • ITALY
    • TABLE 41: Italian Stem Cells Market Growth Prospects in US$ Million by Product Type for the Period 2020
    • TABLE 42: Italian Stem Cells Market by Product Type: Percentage Breakdown of Sales for 2020 and
    • TABLE 43: Italian Demand for Stem Cells in US$ Million by Application: 2020 to
    • TABLE 44: Italian Stem Cells Market Share Breakdown by Application: 2020 VS
  • UNITED KINGDOM
    • TABLE 45: United Kingdom Market for Stem Cells: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020
    • TABLE 46: United Kingdom Stem Cells Market Share Analysis by Product Type: 2020 VS
    • TABLE 47: United Kingdom Demand Estimates and Forecasts for Stem Cells in US$ Million by Application: 2020 to
    • TABLE 48: Stem Cells Market Share Shift in the United Kingdom by Application: 2020 VS
  • REST OF EUROPE
    • TABLE 49: Rest of Europe Stem Cells Market Estimates and Forecasts in US$ Million by Product Type: 2020
    • TABLE 50: Rest of Europe Stem Cells Market Share Breakdown by Product Type: 2020 VS
    • TABLE 51: Rest of Europe Stem Cells Addressable Market Opportunity in US$ Million by Application: 2020
    • TABLE 52: Rest of Europe Stem Cells Market Share Analysis by Application: 2020 VS
  • ASIA-PACIFIC
    • TABLE 53: Stem Cells Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 54: Asia-Pacific Stem Cells Market Share Analysis by Product Type: 2020 VS
    • TABLE 55: Stem Cells Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020
    • TABLE 56: Asia-Pacific Stem Cells Market Share Analysis: A 7-Year Perspective by Application for 2020 and
  • REST OF WORLD
    • TABLE 57: Rest of World Stem Cells Market Estimates and Forecasts in US$ Million by Product Type: 2020 to
    • TABLE 58: Stem Cells Market in Rest of World: Percentage Share Breakdown of Sales by Product Type for 2020 and
    • TABLE 59: Rest of World Stem Cells Market Quantitative Demand Analysis in US$ Million by Application: 2020 to
    • TABLE 60: Rest of World Stem Cells Market Share Analysis by Application: 2020 VS

IV. COMPETITION

  • Total Companies Profiled: 66